These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 24189280

  • 21. Induction therapy with low-dose intravenous cyclophosphamide, oral mizoribine, and steroids for severe lupus nephritis in children.
    Fujinaga S, Kaneko K, Ohtomo Y, Murakami H, Takada M, Akashi S, Hira M, Yamashiro Y.
    Pediatr Nephrol; 2005 Oct; 20(10):1500-3. PubMed ID: 16021476
    [Abstract] [Full Text] [Related]

  • 22. Patterns of drug therapy in newly diagnosed Spanish patients with systemic lupus erythematosus.
    Ruiz-Irastorza G, García M, Espinosa G, Cabezas-Rodríguez I, Mitjavila F, González-León R, Sopeña B, Perales I, Pinilla B, Rodríguez-Carballeira M, López-Dupla JM, Callejas JL, Castro A, Tolosa C, Sánchez-García ME, Pérez-Conesa M, Navarrete-Navarrete N, Rodríguez AP, Herranz MT, Pallarés L, RELES, Autoimmune Diseases Study Group GEAS.
    Clin Exp Rheumatol; 2016 Oct; 34(3):466-72. PubMed ID: 26940538
    [Abstract] [Full Text] [Related]

  • 23. Efficacy and safety of multitarget therapy with cyclophosphamide and tacrolimus for lupus nephritis: a prospective, single-arm, single-centre, open label pilot study in Japan.
    Sakai R, Kurasawa T, Nishi E, Kondo T, Okada Y, Shibata A, Nishimura K, Chino K, Okuyama A, Takei H, Nagasawa H, Amano K.
    Lupus; 2018 Feb; 27(2):273-282. PubMed ID: 28683654
    [Abstract] [Full Text] [Related]

  • 24. Combined mepacrine-hydroxychloroquine treatment in patients with systemic lupus erythematosus and refractory cutaneous and articular activity.
    Ugarte A, Porta S, Ríos R, Martinez-Zapico A, Ortego-Centeno N, Agesta N, Ruiz-Irastorza G.
    Lupus; 2018 Sep; 27(10):1718-1722. PubMed ID: 29635998
    [Abstract] [Full Text] [Related]

  • 25. Rituximab vs mycophenolate and vs cyclophosphamide pulses for induction therapy of active lupus nephritis: a clinical observational study.
    Moroni G, Raffiotta F, Trezzi B, Giglio E, Mezzina N, Del Papa N, Meroni P, Messa P, Sinico AR.
    Rheumatology (Oxford); 2014 Sep; 53(9):1570-7. PubMed ID: 24505125
    [Abstract] [Full Text] [Related]

  • 26. Glucocorticoids and antimalarials in systemic lupus erythematosus: an update and future directions.
    Ugarte A, Danza A, Ruiz-Irastorza G.
    Curr Opin Rheumatol; 2018 Sep; 30(5):482-489. PubMed ID: 29870497
    [Abstract] [Full Text] [Related]

  • 27. Glucocorticoids and irreversible damage in patients with systemic lupus erythematosus.
    Ruiz-Arruza I, Ugarte A, Cabezas-Rodriguez I, Medina JA, Moran MA, Ruiz-Irastorza G.
    Rheumatology (Oxford); 2014 Aug; 53(8):1470-6. PubMed ID: 24681836
    [Abstract] [Full Text] [Related]

  • 28. Outcome of low dose cyclophosphamide for induction phase treatment of lupus nephritis, a single center study.
    Sigdel MR, Kafle MP, Shah DS.
    BMC Nephrol; 2016 Oct 07; 17(1):145. PubMed ID: 27717323
    [Abstract] [Full Text] [Related]

  • 29. Pulsed methylprednisolone therapy compared to high dose prednisone in systemic lupus erythematosus nephritis.
    Garin EH, Sleasman JW, Richard GA, Iravani AA, Fennell RS.
    Eur J Pediatr; 1986 Oct 07; 145(5):380-3. PubMed ID: 3792382
    [Abstract] [Full Text] [Related]

  • 30. Infections in newly diagnosed Spanish patients with systemic lupus erythematosus: data from the RELES cohort.
    González-Echavarri C, Capdevila O, Espinosa G, Suárez S, Marín-Ballvé A, González-León R, Rodríguez-Carballeira M, Fonseca-Aizpuru E, Pinilla B, Pallarés L, Ruiz-Irastorza G, RELES, Autoimmune Diseases Study Group GEAS.
    Lupus; 2018 Dec 07; 27(14):2253-2261. PubMed ID: 30451641
    [Abstract] [Full Text] [Related]

  • 31. Induction therapy with short-term high-dose intravenous cyclophosphamide followed by mycophenolate mofetil in proliferative lupus nephritis.
    Arends S, Berden JH, Grootscholten C, Derksen RH, Berger SP, de Sévaux RG, Voskuyl AE, Bijl M, Dutch Working Party on SLE.
    Neth J Med; 2014 Nov 07; 72(9):481-90. PubMed ID: 25431394
    [Abstract] [Full Text] [Related]

  • 32. Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis.
    Ginzler EM, Dooley MA, Aranow C, Kim MY, Buyon J, Merrill JT, Petri M, Gilkeson GS, Wallace DJ, Weisman MH, Appel GB.
    N Engl J Med; 2005 Nov 24; 353(21):2219-28. PubMed ID: 16306519
    [Abstract] [Full Text] [Related]

  • 33. [Methylprednisolone and cyclophosphamide pulse therapy of severe systemic lupus erythematosus in children].
    Hu J, Li CW, Zhang X, Pi SH, Zhao JS, Chen XY, Liu Y.
    Zhonghua Er Ke Za Zhi; 2003 Jun 24; 41(6):430-4. PubMed ID: 14748998
    [Abstract] [Full Text] [Related]

  • 34. Renal outcome in patients with lupus nephritis using a steroid-free regimen of monthly intravenous cyclophosphamide: a prospective observational study.
    Fischer-Betz R, Chehab G, Sander O, Vordenbäumen S, Voiculescu A, Brinks R, Schneider M.
    J Rheumatol; 2012 Nov 24; 39(11):2111-7. PubMed ID: 22984276
    [Abstract] [Full Text] [Related]

  • 35. Immunosuppressive treatment of the glomerulonephritis of systemic lupus.
    Faedda R, Palomba D, Satta A, Pirisi M, Tanda F, Bartoli E.
    Clin Nephrol; 1995 Dec 24; 44(6):367-75. PubMed ID: 8719548
    [Abstract] [Full Text] [Related]

  • 36. Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide.
    Houssiau FA, Vasconcelos C, D'Cruz D, Sebastiani GD, Garrido Ed Ede R, Danieli MG, Abramovicz D, Blockmans D, Mathieu A, Direskeneli H, Galeazzi M, Gül A, Levy Y, Petera P, Popovic R, Petrovic R, Sinico RA, Cattaneo R, Font J, Depresseux G, Cosyns JP, Cervera R.
    Arthritis Rheum; 2002 Aug 24; 46(8):2121-31. PubMed ID: 12209517
    [Abstract] [Full Text] [Related]

  • 37. Azathioprine/methylprednisolone versus cyclophosphamide in proliferative lupus nephritis. A randomized controlled trial.
    Grootscholten C, Ligtenberg G, Hagen EC, van den Wall Bake AW, de Glas-Vos JW, Bijl M, Assmann KJ, Bruijn JA, Weening JJ, van Houwelingen HC, Derksen RH, Berden JH, Dutch Working Party on Systemic Lupus Erythematosus.
    Kidney Int; 2006 Aug 24; 70(4):732-42. PubMed ID: 16820790
    [Abstract] [Full Text] [Related]

  • 38. [Cyclophosphamide-induced lupus flare in diffuse proliferative lupus nephropathy].
    Heras M, Saiz A, Fernández-Reyes MJ, Sánchez R, Zurita P, Urrego C.
    Nefrologia; 2011 Aug 24; 31(2):231-3. PubMed ID: 21461001
    [No Abstract] [Full Text] [Related]

  • 39. [Treatment of lupus nephritis].
    Novak S.
    Lijec Vjesn; 2014 Aug 24; 136(7-8):215-9. PubMed ID: 25327009
    [Abstract] [Full Text] [Related]

  • 40. [Appraisal of renal failure reversing therapies in lupus nephritis].
    Yang X, Liang L, Zhan Z, Ye Y, Liu Y, Yu X, Chen W, Yin P.
    Zhonghua Nei Ke Za Zhi; 2001 Feb 24; 40(2):113-6. PubMed ID: 11798566
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.